NFE2L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.661000E-01
Normal-vs-Stage2
7.430800E-01
Normal-vs-Stage3
2.982600E-01
Normal-vs-Stage4
1.555430E-01
Stage1-vs-Stage2
9.102800E-01
Stage1-vs-Stage3
1.300150E-01
Stage1-vs-Stage4
1.600180E-01
Stage2-vs-Stage3
1.778850E-01
Stage2-vs-Stage4
8.409600E-02
Stage3-vs-Stage4
2.320000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.728800E-01
Normal-vs-AfricanAmerican
4.162000E-01
Normal-vs-Asian
8.131600E-01
Caucasian-vs-AfricanAmerican
2.096000E-01
Caucasian-vs-Asian
7.727800E-01
AfricanAmerican-vs-Asian
6.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.435000E-01
Normal-vs-Female
7.975200E-01
Male-vs-Female
8.903400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.536000E-01
Normal-vs-Age(41-60Yrs)
3.979600E-01
Normal-vs-Age(61-80Yrs)
9.529200E-01
Normal-vs-Age(81-100Yrs)
5.666600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.646000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.862800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.860800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.998400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.161790E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.361600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.195600E-01
Normal-vs-Daily Drinker
7.001000E-01
Normal-vs-Weekly Drinker
9.585000E-01
Normal-vs-Occasional Drinker
4.645200E-01
Normal-vs-Social Drinker
9.245800E-01
Non Drinker-vs-Daily Drinker
8.701000E-01
Non Drinker-vs-Weekly Drinker
4.640000E-01
Non Drinker-vs-Occasional Drinker
2.561700E-02
Non Drinker-vs-Social Drinker
3.902400E-01
Daily Drinker-vs-Weekly Drinker
4.450600E-01
Daily Drinker-vs-Occasional Drinker
3.734200E-02
Daily Drinker-vs-Social Drinker
3.755200E-01
Weekly Drinker-vs-Occasional Drinker
2.553200E-01
Weekly Drinker-vs-Social Drinker
9.596200E-01
Occasional Drinker-vs-Social Drinker
2.331400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.446830E-01
Normal-vs-Grade 2
8.615200E-03
Normal-vs-Grade 3
5.584500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.502720E-03
Grade 1-vs-Grade 3
6.582600E-03
Grade 1-vs-Grade 4
1.446830E-01
Grade 2-vs-Grade 3
7.267600E-01
Grade 2-vs-Grade 4
8.615200E-03
Grade 3-vs-Grade 4
5.584500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.165200E-01
Normal-vs-NonDiabetic
8.979400E-01
Diabetic-vs-NonDiabetic
4.621800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.957600E-01
Normal-vs-NoPancreatitis
9.013400E-01
Pancreatitis-vs-NoPancreatitis
6.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.120600E-01
Normal-vs-N1
6.902400E-01
N0-vs-N1
7.943500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.152400E-01
Normal-vs-TP53-NonMutant
9.696600E-01
TP53-Mutant-vs-TP53-NonMutant
9.118500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
